Stifel Financial Corp Has $16.74 Million Stock Holdings in STERIS plc (NYSE:STE)

Stifel Financial Corp decreased its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 6.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 81,441 shares of the medical equipment provider's stock after selling 5,979 shares during the quarter. Stifel Financial Corp owned approximately 0.08% of STERIS worth $16,743,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. Magnolia Capital Advisors LLC increased its position in STERIS by 1.9% during the 4th quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider's stock worth $521,000 after buying an additional 48 shares during the period. SkyView Investment Advisors LLC increased its position in STERIS by 1.6% during the 3rd quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider's stock worth $765,000 after buying an additional 51 shares during the period. Park Edge Advisors LLC increased its position in STERIS by 1.1% during the 4th quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider's stock worth $958,000 after buying an additional 51 shares during the period. Citizens Financial Group Inc. RI increased its position in STERIS by 5.9% during the 4th quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider's stock worth $201,000 after buying an additional 54 shares during the period. Finally, Opal Wealth Advisors LLC increased its position in shares of STERIS by 5.7% in the fourth quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider's stock worth $230,000 after purchasing an additional 60 shares during the period. Institutional investors and hedge funds own 94.69% of the company's stock.

STERIS Price Performance

NYSE:STE traded up $0.26 on Monday, hitting $225.26. The company had a trading volume of 610,377 shares, compared to its average volume of 526,408. The stock has a market capitalization of $22.13 billion, a price-to-earnings ratio of 47.83 and a beta of 0.87. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The firm has a 50 day moving average of $222.97 and a two-hundred day moving average of $218.84. STERIS plc has a 52 week low of $200.98 and a 52 week high of $248.24.

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, research analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were issued a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.01%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS's payout ratio is 48.41%.

Analyst Upgrades and Downgrades

STE has been the topic of a number of recent analyst reports. Stephens restated an "overweight" rating and issued a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. Needham & Company LLC restated a "hold" rating on shares of STERIS in a research report on Monday, April 7th. JMP Securities restated a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a research report on Thursday, April 10th. Finally, Piper Sandler lifted their target price on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.